These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 16731906

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
    Rao G, Rekhtman N, Cheng G, Krasikov T, Skoultchi AI.
    Oncogene; 1997 Jan 09; 14(1):123-31. PubMed ID: 9010239
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling.
    Yu WM, Hawley TS, Hawley RG, Qu CK.
    Oncogene; 2003 Sep 04; 22(38):5995-6004. PubMed ID: 12955078
    [Abstract] [Full Text] [Related]

  • 45. Induction of sequence-specific DNA-binding factors by erythropoietin and the spleen focus-forming virus.
    Ohashi T, Masuda M, Ruscetti SK.
    Blood; 1995 Mar 15; 85(6):1454-62. PubMed ID: 7888668
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Friend erythroleukemia virus complex: role of viral components in modifying erythroid differentiation in mice.
    Fagg B, Ostertag W.
    J Natl Cancer Inst; 1982 Mar 15; 68(3):457-60. PubMed ID: 6950173
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Loss of pathogenicity of spleen focus-forming virus after pseudotyping with Akv.
    Jones KS, Ruscetti S, Lilly F.
    J Virol; 1988 Feb 15; 62(2):511-8. PubMed ID: 2826812
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Virus and cell requirements for Friend virus granulocytic leukemogenesis in long-term bone marrow cultures of NIH swiss [N:NIH(S)] mice.
    Greenberger JS, Newburger PE, Lipton JM, Moloney WC, Sakakeeny MA, Jackson PL.
    J Natl Cancer Inst; 1980 Apr 15; 64(4):867-78. PubMed ID: 6928998
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Role of gp55 in restoring the sensitivity of Friend murine erythroleukemia cells to erythropoietin by exposure to dimethyl sulfoxide.
    Lin TS, Ishiguro K, Sartorelli AC.
    Oncol Res; 1998 Apr 15; 10(4):175-84. PubMed ID: 9778688
    [Abstract] [Full Text] [Related]

  • 56. A novel Stat3 binding motif in Gab2 mediates transformation of primary hematopoietic cells by the Stk/Ron receptor tyrosine kinase in response to Friend virus infection.
    Ni S, Zhao C, Feng GS, Paulson RF, Correll PH.
    Mol Cell Biol; 2007 May 15; 27(10):3708-15. PubMed ID: 17353274
    [Abstract] [Full Text] [Related]

  • 57. A dominant negative erythropoietin (EPO) receptor inhibits EPO-dependent growth and blocks F-gp55-dependent transformation.
    Barber DL, DeMartino JC, Showers MO, D'Andrea AD.
    Mol Cell Biol; 1994 Apr 15; 14(4):2257-65. PubMed ID: 8139531
    [Abstract] [Full Text] [Related]

  • 58. Lack of retrovirus gene expression in somatic cell hybrids of friend cells and teratocarcinoma cells with a teratocarcinoma phenotype.
    Asche W, Colletta G, Warnecke G, Nobis P, Pennie S, King RM, Ostertag W.
    Mol Cell Biol; 1984 May 15; 4(5):923-30. PubMed ID: 6727874
    [Abstract] [Full Text] [Related]

  • 59. Roles of helper and defective retroviral genomes in murine erythroleukemia: studies of spleen focus-forming virus in the absence of helper.
    Bestwick RK, Hankins WD, Kabat D.
    J Virol; 1985 Dec 15; 56(3):660-4. PubMed ID: 2999422
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.